Cargando…
Vaccine-Mediated Immunity Against Dengue and the Potential for Long-Term Protection Against Disease
It is estimated that over 2.5 billion people are at risk for contracting dengue, a virus responsible for 50–390 million infections in addition to thousands of hospitalizations and deaths each year. There are no licensed vaccines available to combat this pathogen but substantial efforts are underway...
Autor principal: | Slifka, Mark K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018518/ https://www.ncbi.nlm.nih.gov/pubmed/24834067 http://dx.doi.org/10.3389/fimmu.2014.00195 |
Ejemplares similares
-
Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity
por: Slifka, Mark K., et al.
Publicado: (1996) -
Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans
por: McLean, Chelsea, et al.
Publicado: (2023) -
Vaccine-mediated protection against Campylobacter-associated enteric disease
por: Quintel, Benjamin K., et al.
Publicado: (2020) -
Protective Immunity and Vaccination Against Cutaneous Leishmaniasis
por: Okwor, Ifeoma, et al.
Publicado: (2012) -
Sculpting humoral immunity through dengue vaccination to enhance protective immunity
por: Crill, Wayne D., et al.
Publicado: (2012)